Helexva

Pittsburgh, United States

Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.

$2.3M raised

Mar 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Helexva raised?

Helexva has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in March 2024.

Who are Helexva's investors?

Helexva's investors include UPMC Enterprises.

Where is Helexva headquartered?

Helexva is headquartered in Pittsburgh, United States.

What does Helexva do?

Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.

What stage is Helexva at?

Helexva is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2024.

MLA

"Helexva — Funding & Investors." VCBacked, March 2, 2024, https://www.vcbacked.co/company/helexva. Accessed July 2, 2026.

APA

VCBacked. (2024). Helexva — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/helexva

Wikipedia (cite web)

{{cite web |title=Helexva — Funding & Investors |url=https://www.vcbacked.co/company/helexva |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2024.